🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Drug Gaining Traction Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Viewers are encouraged to contact these profiles privately for source information, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and assertions of rapid British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Worries

However, physicians and pharmacists have cautions that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could lead to users injecting products of uncertain source.

Several experts said the popularity for the experimental drug could be connected to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate medicines, marketing, and customer laws, risking penalties, prosecution or prison.

Platform Reaction and Material Removal

According to the social media company, the service has taken down violative content and prohibited associated keywords and query recommendations. The company stated it was committed to maintaining the service safe and allocating resources in strengthening compliance measures.

Digital Trading Activities

Research also found communities with up to nine thousand members marketing retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, filled with photos of weight loss, positive testimonials and step-by-step instructions for mixing or injecting at home.

Within minutes of joining one group, a seller shared WhatsApp details, where most purchases occur. The seller provided an guidebook and promised delivery within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about weight, medical conditions or past usage.

Item Information and Costs

Within these groups, posts show dark colored parcels with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with sterile water, or pre-filled pens usually priced at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service said it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering materials they can’t verify. Even if the research behind retatrutide is sound, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service linked the surge in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.

Her team has already seen individuals injured by personal administration from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational product not yet authorized … may subject users to possibly serious health risks”.